Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Short-term Investments: 2010-2024

Historic Short-term Investments for Ligand Pharmaceuticals (LGND) over the last 14 years, with Dec 2024 value amounting to $183.9 million.

  • Ligand Pharmaceuticals' Short-term Investments rose 236.58% to $525.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $525.1 million, marking a year-over-year increase of 236.58%. This contributed to the annual value of $183.9 million for FY2024, which is 24.77% up from last year.
  • Per Ligand Pharmaceuticals' latest filing, its Short-term Investments stood at $183.9 million for FY2024, which was up 24.77% from $147.4 million recorded in FY2023.
  • Ligand Pharmaceuticals' 5-year Short-term Investments high stood at $363.6 million for FY2020, and its period low was $147.4 million during FY2023.
  • In the last 3 years, Ligand Pharmaceuticals' Short-term Investments had a median value of $166.9 million in 2022 and averaged $166.0 million.
  • As far as peak fluctuations go, Ligand Pharmaceuticals' Short-term Investments crashed by 63.58% in 2020, and later increased by 24.77% in 2024.
  • Ligand Pharmaceuticals' Short-term Investments (Yearly) stood at $363.6 million in 2020, then declined by 11.55% to $321.6 million in 2021, then tumbled by 48.11% to $166.9 million in 2022, then fell by 11.69% to $147.4 million in 2023, then rose by 24.77% to $183.9 million in 2024.